{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:50:33Z","timestamp":1784893833065,"version":"3.55.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) shows potential in treating androgenetic alopecia but lacks evidence for endocrine-induced alopecia (EIA) or persistent chemotherapy-induced alopecia (pCIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate safety and efficacy of PRP in breast cancer survivors with EIA or pCIA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>In this single-center, randomized, controlled trial, EIA and pCIA patients received PRP injections on one side of their scalp monthly for 3 months. Evaluations occurred at baseline and at week 12, followed by an optional cross-arm at week 24. The primary outcome was difference in global assessment scale (GAS) at week 12, assessed by a blinded investigator. Secondary outcomes included adverse events, hair-related quality of life, trichoscopic data, and circulating tumor cell (CTC) assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Fifteen EIA and 12 pCIA patients enrolled. GAS improved from baseline to week 12 (+1.2 each,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .001) but not statistically significant between treated and untreated sides (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &gt; .05). Hair density increased for both sides (+21 and +16 hairs\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , respectively,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .05), without difference between the sides (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &gt; .05). Quality of life showed no improvement (41.1\u201339.4,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &gt; .05). Adverse events included grade 1 to grade 3 scalp pain. Two of 12 CTC assays detected malignant cells in PRP, but no tumor seeding events were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>PRP may increase hair density in EIA and pCIA patients and showed no adverse cancer outcomes or tumor seeding. Results may be confounded by possible PRP diffusion in split-scalp study design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>ClinicalTrials.gov ID<\/jats:title>\n                    <jats:p>NCT04459650.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004755","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T08:01:02Z","timestamp":1751961662000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study"],"prefix":"10.1097","volume":"52","author":[{"given":"Anthony","family":"Rossi","sequence":"first","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pan","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"},{"name":"SUNY Downstate Health Sciences University, Brooklyn, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Menzer","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"},{"name":"Department of Dermatology, Heidelberg University Hospital and National Center for Tumor Diseases (NCT), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leore","family":"Lavin","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"},{"name":"Icahn School of Medicine at Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Aleissa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King Abdulaziz University and University Hospital, Jeddah, Saudi Arabia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Aleisa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King Saud University, Riyadh, Saudi Arabia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Alshaikh","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dranitsaris","sequence":"additional","affiliation":[{"name":"Department of Public Health, Syracuse University, Syracuse, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Dusza","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Bravo","sequence":"additional","affiliation":[{"name":"Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[{"name":"Dermatology Division, Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, New York;"},{"name":"Symptom Management Program, Perlmutter Cancer Center, NYU Langone Hospital\u2014Long Island, Mineola, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamadermatol.2021.3676","article-title":"Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors","volume":"157","author":"Bhoyrul","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40487-023-00225-8","article-title":"The future of breast cancer research in the survivorship field","volume":"11","author":"Soldato","year":"2023","journal-title":"Oncol Ther"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0738-081X(00)00127-9","article-title":"The psychology of hair loss and its implications for patient care","volume":"19","author":"Cash","year":"2001","journal-title":"Clin Dermatol"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy\u2013induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R5-20251218","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair disorders in cancer survivors","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia","volume":"28","author":"Tr\u00fceb","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"R7-20251218","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"R8-20251218","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10549-017-4204-x","article-title":"Chemotherapy-induced irreversible alopecia in early breast cancer patients","volume":"163","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R9-20251218","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/ijms21082702","article-title":"Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil, finasteride, and adult stem cell-based therapy","volume":"21","author":"Gentile","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R10-20251218","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaad.2020.07.006","article-title":"Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial","volume":"83","author":"Shapiro","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R11-20251218","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/biomedicines12010007","article-title":"Platelet-rich plasma (PRP) in dermatology: cellular and molecular mechanisms of action","volume":"12","author":"Vladulescu","year":"2023","journal-title":"Biomedicines"},{"key":"R12-20251218","doi-asserted-by":"crossref","first-page":"13030\/qt8s43026c","DOI":"10.5070\/D3247040910","article-title":"Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review","volume":"24","author":"Girijala","year":"2018","journal-title":"Dermatol Online J"},{"key":"R13-20251218","first-page":"147","article-title":"Platelet-rich plasma in dermatology","volume":"16","author":"Langer","year":"2014","journal-title":"JK Sci"},{"key":"R14-20251218","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/DSS.0000000000001198","article-title":"Platelet-rich plasma in combination with 5% minoxidil topical solution and 1 mg oral finasteride for the treatment of androgenetic alopecia: a randomized placebo-controlled, double-blind, half-head study","volume":"44","author":"Alves","year":"2018","journal-title":"Dermatol Surg"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21037\/sci.2017.11.01","article-title":"Alopecia and platelet-derived therapies","volume":"4","author":"Cole","year":"2017","journal-title":"Stem Cell Investig"},{"key":"R16-20251218","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"key":"R17-20251218","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0974-7753.114700","article-title":"A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study","volume":"5","author":"Dhurat","year":"2013","journal-title":"Int J Trichology"},{"key":"R18-20251218","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group","volume":"39","author":"Kaufman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R19-20251218","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s001050051293","article-title":"[Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases]","volume":"52","author":"Fischer","year":"2001","journal-title":"Der Hautarzt"},{"key":"R20-20251218","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jamadermatol.2021.5743","article-title":"Relative efficacy of minoxidil and the 5-\u03b1 reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis","volume":"158","author":"Gupta","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R21-20251218","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"key":"R22-20251218","doi-asserted-by":"crossref","first-page":"998623","DOI":"10.3389\/fmed.2022.998623","article-title":"Hair regrowth treatment efficacy and resistance in androgenetic alopecia: a systematic review and continuous Bayesian network meta-analysis","volume":"9","author":"Feldman","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R23-20251218","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/jocd.16185","article-title":"The role of platelet-rich plasma in androgenetic alopecia: a systematic review","volume":"23","author":"Donnelly","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"R24-20251218","doi-asserted-by":"crossref","first-page":"1058431","DOI":"10.3389\/fmed.2022.1058431","article-title":"Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: a systematic review","volume":"9","author":"Tejapira","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R25-20251218","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/09546634.2017.1303571","article-title":"Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature","volume":"28","author":"Ayatollahi","year":"2017","journal-title":"J Dermatol Treat"},{"key":"R26-20251218","first-page":"24","article-title":"Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis","volume":"21","author":"Cruciani","year":"2023","journal-title":"Blood Transfus"},{"key":"R27-20251218","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/jocd.14813","article-title":"The effect of placebo in split-scalp and whole-head platelet-rich plasma trials for androgenetic alopecia differs: findings from a systematic review with quantitative evidence syntheses","volume":"21","author":"Gupta","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R28-20251218","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/JCAS.JCAS_192_19","article-title":"Tumescent anesthesia for dermatosurgical procedures other than liposuction","volume":"13","author":"Uttamani","year":"2020","journal-title":"J Cutan Aesthet Surg"},{"key":"R29-20251218","doi-asserted-by":"crossref","first-page":"dju066","DOI":"10.1093\/jnci\/dju066","article-title":"Circulating tumor cells predict survival in early average-to-high risk breast cancer patients","volume":"106","author":"Rack","year":"2014","journal-title":"J Natl Cancer Inst"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:00:30Z","timestamp":1766084430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004755","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]}}}